Lipid formulated compositions and methods for inhibiting expression of EG5 and VEGF genes

Lipid formulated compositions and methods for inhibiting expression of EG5 and VEGF genes

  • CN 103,370,054 A
  • Filed: 11/09/2011
  • Published: 10/23/2013
  • Est. Priority Date: 11/09/2010
  • Status: Active Application
First Claim
Patent Images

1. A treatment have in requisition for experimenter'"'"'s the method for carcinoma of endometrium, comprise to described experimenter and use compositions at least about 0.7mg/kg (based on the siRNA gross weight with the mg/kg weighing machine), described compositions comprises(i)DLinDMA;

  • (ii)DPPC;

    (iii)PEG2000-C-DMA;

    (iv) cholesterol;

    (v) siRNA of targeting Eg5/KSP;

    With(vi) siRNA of targeting VEGF.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×